The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
Abstract Purpose Vincristine (VCR) is a chemotherapeutic agent used in the treatment of pediatric oncology patients, but its main toxicity is VCR‐induced peripheral neuropathy (VIPN). However, whether VIPN has an effect on health‐related quality of life (HR‐QoL) in children during treatment is unkno...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5e35beb568340dda7f7b38abc4d5585 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e5e35beb568340dda7f7b38abc4d5585 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e5e35beb568340dda7f7b38abc4d55852021-11-22T09:08:48ZThe association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer2045-763410.1002/cam4.4289https://doaj.org/article/e5e35beb568340dda7f7b38abc4d55852021-11-01T00:00:00Zhttps://doi.org/10.1002/cam4.4289https://doaj.org/toc/2045-7634Abstract Purpose Vincristine (VCR) is a chemotherapeutic agent used in the treatment of pediatric oncology patients, but its main toxicity is VCR‐induced peripheral neuropathy (VIPN). However, whether VIPN has an effect on health‐related quality of life (HR‐QoL) in children during treatment is unknown. Therefore, the aim of our study was to investigate the association between VIPN and HR‐QoL in children starting treatment for cancer. Methods Measurements of VIPN were performed using two tools: Common Terminology Criteria for Adverse Events (CTCAE) and pediatric‐modified Total Neuropathy Score (ped‐mTNS). Assessment of HR‐QoL was done with self‐ and proxy assessment of the Cancer and Generic module of the Pediatric Cancer Quality of Life Inventory™ (PedsQL). Results In total, N = 86 children were included. HR‐QoL of children with VIPN (n = 67%, 76%) was significantly lower in comparison with children without VIPN: estimated Total score of PedsQL Generic (proxy) 84.57; β = −8.96 and 95% confidence interval (CI) −14.48 to −3.43; p = 0.002, estimated PedsQL Generic Total score (self‐reported): 85.16, β = −8.38 (95% CI: −13.76 to −3.00); p = 0.003. Similar results were found in the Pain and Hurt domain of the PedsQL Cancer (pain: estimated score [proxy]: 85.28, β = −9.94 [95%CI: −16.44 to −3.45], p = 0.003; hurt: estimated score [self‐report] 97.57, β = −19.15 [95%CI: −26.82 to −11.48], p < 0.001). Conclusion VIPN results in a significant reduction of HR‐QoL in children under treatment for a malignancy, which means that VIPN is important for the well‐being of pediatric oncology patients. Therefore, this study underlines the importance of optimizing treatment with VCR, thereby aiming to reduce VIPN while maintaining efficacy.Mirjam E. van deVeldeMarleen. H. van denBergGertjan J. L. KaspersFloor C. H. AbbinkJos W. R. TwiskInge M. van derSluisCor van denBosMarry M. van denHeuvel‐EibrinkHeidi SegersChristophe ChantrainJutte van derWerff Ten BoschLeen WillemsRaphaële R. L. vanLitsenburgWileyarticlecancerchildrenneurotoxicityPedsQLNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Medicine, Vol 10, Iss 22, Pp 8172-8181 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cancer children neurotoxicity PedsQL Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
cancer children neurotoxicity PedsQL Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mirjam E. van deVelde Marleen. H. van denBerg Gertjan J. L. Kaspers Floor C. H. Abbink Jos W. R. Twisk Inge M. van derSluis Cor van denBos Marry M. van denHeuvel‐Eibrink Heidi Segers Christophe Chantrain Jutte van derWerff Ten Bosch Leen Willems Raphaële R. L. vanLitsenburg The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
description |
Abstract Purpose Vincristine (VCR) is a chemotherapeutic agent used in the treatment of pediatric oncology patients, but its main toxicity is VCR‐induced peripheral neuropathy (VIPN). However, whether VIPN has an effect on health‐related quality of life (HR‐QoL) in children during treatment is unknown. Therefore, the aim of our study was to investigate the association between VIPN and HR‐QoL in children starting treatment for cancer. Methods Measurements of VIPN were performed using two tools: Common Terminology Criteria for Adverse Events (CTCAE) and pediatric‐modified Total Neuropathy Score (ped‐mTNS). Assessment of HR‐QoL was done with self‐ and proxy assessment of the Cancer and Generic module of the Pediatric Cancer Quality of Life Inventory™ (PedsQL). Results In total, N = 86 children were included. HR‐QoL of children with VIPN (n = 67%, 76%) was significantly lower in comparison with children without VIPN: estimated Total score of PedsQL Generic (proxy) 84.57; β = −8.96 and 95% confidence interval (CI) −14.48 to −3.43; p = 0.002, estimated PedsQL Generic Total score (self‐reported): 85.16, β = −8.38 (95% CI: −13.76 to −3.00); p = 0.003. Similar results were found in the Pain and Hurt domain of the PedsQL Cancer (pain: estimated score [proxy]: 85.28, β = −9.94 [95%CI: −16.44 to −3.45], p = 0.003; hurt: estimated score [self‐report] 97.57, β = −19.15 [95%CI: −26.82 to −11.48], p < 0.001). Conclusion VIPN results in a significant reduction of HR‐QoL in children under treatment for a malignancy, which means that VIPN is important for the well‐being of pediatric oncology patients. Therefore, this study underlines the importance of optimizing treatment with VCR, thereby aiming to reduce VIPN while maintaining efficacy. |
format |
article |
author |
Mirjam E. van deVelde Marleen. H. van denBerg Gertjan J. L. Kaspers Floor C. H. Abbink Jos W. R. Twisk Inge M. van derSluis Cor van denBos Marry M. van denHeuvel‐Eibrink Heidi Segers Christophe Chantrain Jutte van derWerff Ten Bosch Leen Willems Raphaële R. L. vanLitsenburg |
author_facet |
Mirjam E. van deVelde Marleen. H. van denBerg Gertjan J. L. Kaspers Floor C. H. Abbink Jos W. R. Twisk Inge M. van derSluis Cor van denBos Marry M. van denHeuvel‐Eibrink Heidi Segers Christophe Chantrain Jutte van derWerff Ten Bosch Leen Willems Raphaële R. L. vanLitsenburg |
author_sort |
Mirjam E. van deVelde |
title |
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
title_short |
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
title_full |
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
title_fullStr |
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
title_full_unstemmed |
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
title_sort |
association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/e5e35beb568340dda7f7b38abc4d5585 |
work_keys_str_mv |
AT mirjamevandevelde theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT marleenhvandenberg theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT gertjanjlkaspers theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT floorchabbink theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT joswrtwisk theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT ingemvandersluis theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT corvandenbos theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT marrymvandenheuveleibrink theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT heidisegers theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT christophechantrain theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT juttevanderwerfftenbosch theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT leenwillems theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT raphaelerlvanlitsenburg theassociationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT mirjamevandevelde associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT marleenhvandenberg associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT gertjanjlkaspers associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT floorchabbink associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT joswrtwisk associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT ingemvandersluis associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT corvandenbos associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT marrymvandenheuveleibrink associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT heidisegers associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT christophechantrain associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT juttevanderwerfftenbosch associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT leenwillems associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer AT raphaelerlvanlitsenburg associationbetweenvincristineinducedperipheralneuropathyandhealthrelatedqualityoflifeinchildrenwithcancer |
_version_ |
1718417828486316032 |